Turnstone BiologicsTSBX
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 24 institutions reported holding Turnstone Biologics Corp. (TSBX) in their 13F filings, down 23 from Q2 2024. 1 opened new positions and 24 sold out. The largest holders were Orbimed Advisors LLC ($1.7M), FMR LLC ($653K) and PFM Health Sciences, LP ($519K). 3 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Turnstone Biologics Corp.
- CUSIP
- 90042W100
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $19K |
| Exits | 24 | $2.8M |
All 13F filers, Q2 2024 → Q3 2024: 149,691 shares bought and 1,410,121 shares sold, net −1,260,430 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 24 holders
| Orbimed Advisors LLC | 0.03% | No change | 3,099,265 | $1.7M |
| FMR LLC | 0.00% | Add +3.3% | 1,172,987 | $653K |
| PFM Health Sciences, LP | 0.03% | No change | 932,348 | $519K |
| Point72 Asset Management | 0.00% | Reduce -16.7% | 932,226 | $519K |
| Bank of America Corp. | 0.00% | Add +0.1% | 911,741 | $508K |
| Takeda Pharmaceutical Co. Ltd. | 1.31% | No change | 895,824 | $499K |
| Citadel Advisors | 0.00% | Add +0.7% | 689,213 | $384K |
| Vanguard Group Inc. | 0.00% | No change | 578,995 | $323K |
| 72 Investment Holdings, LLC | 0.66% | No change | 549,980 | $306K |
| Sectoral Asset Management Inc. | 0.17% | No change | 517,648 | $288K |
| ExodusPoint Capital Management, LP | 0.00% | Reduce -2.3% | 454,026 | $253K |
| FIL Ltd | 0.00% | No change | 192,657 | $107K |
| Geode Capital Management, LLC | 0.00% | Add +84.6% | 132,819 | $74K |
| Barclays PLC | 0.00% | Reduce -5.1% | 110,044 | $61K |
| Millennium Management | 0.00% | Reduce -18.1% | 103,028 | $57K |
| Balyasny Asset Management L.P. | 0.00% | Reduce -7.1% | 49,880 | $28K |
| BlackRock, Inc. | 0.00% | — | 42,928 | $24K |
| Acadian Asset Management LLC | 0.00% | New | 36,454 | $19K |
| Northern Trust Corp. | 0.00% | Reduce -80.5% | 18,405 | $10K |
| UBS Group AG | 0.00% | Add +586.2% | 10,643 | $6K |
| Morgan Stanley | 0.00% | Reduce -68.0% | 6,001 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -52.6% | 4,976 | $3K |
| Catalyst Funds Management Pty Ltd | 0.00% | Reduce -79.5% | 800 | $446 |
| JPMorgan Chase & Co. | 0.00% | Reduce -97.7% | 158 | $88 |
"% of holder's portfolio" is TSBX's weight in each manager's 13F, not the share of Turnstone Biologics Corp. the manager owns.